The concern is that Marrow’s best recruiting work came in Ohio and Kentucky, where the Wildcats appear to have little traction with the 2026 high school class right now.

Vince Marrow’s expected move to Louisville leaves Kentucky football with key roles to fill, raising questions about Mark Stoops’ future leadership.

‘My daughter only knew hospitals until I had a son whose bone marrow saved her life’ How far would you go to save your child? For Mina Holland, her second baby became his sister’s saviour in ...

Data from the phase 3 IRAKLIA trial (NCT05405166) showed the on-body delivery system (OBDS) for isatuximab, used to treat patients with multiple myeloma, matched the response rate and ...

Specifically, the percentage of patients with high tumor burden was lower (6.3% vs 17.4%) among progression-free patients, who also had numerically lower median soluble B-cell maturation antigen ...

Eligible patients were 18 to 75 years old with newly diagnosed multiple myeloma and an ECOG performance status of 2 or less. The median age was 60.8 years in the DKRd group and 60.7 years in the KRd ...

The trispecific antibody JNJ-79635322 (JNJ-5322) showed a manageable safety profile and responses similar to chimeric antigen receptor (CAR) T-cell therapy in patients with relapsed/refractory ...

Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI® with one-third of patients with relapsed/refractory multiple myeloma progression-free ...

The Phase 1b /2 CARTITUDE-1 study (n=97) evaluated CARVYKTI ® for the treatment of heavily pre-treated patients with RRMM. Patients who remained progression free for at least five years (n=32 ...

A Pennington Gap woman in need of a bone marrow transplant is hoping for a match. Tue, 24 Jun 2025 12:05:52 GMT (1750766752149) Story Infinite Scroll - News3 v1.0.0 (common) ...

Ichnos Glenmark Innovation (IGI), a biotechnology company focused on cancer treatments, has announced positive results from an early-stage global study of its investigational drug for patients with ...